Home/Filings/4/0001746473-25-000009
4//SEC Filing

Coulie Bernard 4

Accession 0001746473-25-000009

CIK 0001746473other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 5:58 PM ET

Size

12.7 KB

Accession

0001746473-25-000009

Insider Transaction Report

Form 4
Period: 2025-01-23
Coulie Bernard
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2025-01-23+162,500593,017 total
  • Award

    Stock Option (Right to Buy)

    2025-01-23+325,000325,000 total
    Exercise: $11.14Exp: 2035-01-23Common Stock (325,000 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    409,317
Footnotes (3)
  • [F1]These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
  • [F2]Shares held by The Coulie/Leyman Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001808895

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 5:58 PM ET
Size
12.7 KB